Recombinant human placental RNase inhibitor expressed in E. coli strain; completely inhibits RNase A, B and C activity. It maintains fully activity in highly demanding conditions (at least 4 weeks incubation at 37°C, 24 hours at 50°C, 2 hours at 60°C and 10 cycles of freeze/thaw). It is free of any nuclease activity contamination.
We use some essential cookies to make this website work. These cookies aren't used to track you. We'd
like
to set additional cookies to understand how you use our website. This information is used to improve
our
services.